期刊文献+

基于中心审方模式的骨科围术期止吐药物合理使用的药学实践 被引量:3

Pharmaceutical Practice in Rational Use of Antiemetic Drugs during Perioperative Period in Orthopedic Department based on Prescription Review Center System
下载PDF
导出
摘要 目的:分析中心审方系统对本院骨科围术期止吐药物预防使用的影响。方法:利用信息系统统计本院2019年7月-2020年6月骨科围术期止吐药物的使用情况,回顾性分析开展中心审方前后本院骨科围术期止吐药物使用准确率、用药疗程变化及用法用量合理性。结果:本院实行中心审方后,外科围术期止吐药物的合理使用率由66.41%上升到97.35%,药师人工审核数为856条,其中超剂量给药是主要问题,其次是给药频率不合适。经过专项审方模式的推广,问题医嘱减少为30条,比实施前减少94.4%。结论:基于中心审方模式的药学干预对于骨科围术期止吐药物的效果确切,可以有效提升围术期止吐药物的合理使用。 Objective:To investigate the application of prescription review center system in the rational use of antiemetic drugs during perioperative period in orthopedic department.Method:The use of antiemetic drugs in indication,single dosage and course of treatment during the perioperative period in orthopedic department from July 2019 to June 2020 were analyzed retrospectively.Result:The reasonable use rate of antiemetic drugs in doctors’orders increased from 66.41%before the intervention to 97.35%after the intervention.856 of medical orders were passed by pharmacists.The main unreasonable use was overdosing which exceeding the recommended dose,followed by the over-frequency use of antiemetic drugs.After the promotion of special prescription review mode,the number of problematic medical orders was reduced to 30 items,94.4%less than before implementation of the project.Conclusion:The effect of pharmaceutical intervention based on prescription review center system in orthopedic department is definite,which can effectively promote the rational use of antiemetic drugs in perioperative period.
作者 王玮 张智琪 高杰 虞勋 郑晓娴 包建安 朱建国 缪丽燕 WANG Wei;ZHANG Zhiqi;GAO Jie;YU Xun;ZHENG Xiaoxian;BAO Jian’an;ZHU Jianguo;MIAO Liyan(The First Affiliated Hospital of Suzhou University,Suzhou 215006,Chinav;不详)
出处 《中外医学研究》 2021年第26期182-185,共4页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 国家重大新药创制科技重大专项项目(2017ZX09304021)。
关键词 中心审方平台 围术期 止吐药物 合理用药 Prescription review center system Perioperative period Antiemetic drugs Rational use of drugs
  • 相关文献

参考文献12

二级参考文献96

  • 1杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 2陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 3卫生部.处方管理办法[s].卫生部令第53号,2007.
  • 4NCCN Clinical Practice Guidelines in Oncology: Antiemesis. version 1. 2014[EB/OL] .[2014-02-25]. http://www. nccn. orgl professionalsl physician_glsl pdfl antiemesis. pdf.
  • 5MASCC/ESMO. Antiemetic Guidelines 2013[EB/OL].[2014- 02-25]. http://www. mascc. orgl antiemetic-guidelines; 2013 MASccTM?.
  • 6Gralla RJ, Osoba D, Krismg, et al. Recommendations for the use of anti emetics : evidence-based, clinical practice guidelines[J] .J Clin Oncol, 1999, 17(9): 2971-2994.
  • 7徐建国.手术后恶心呕吐(PONV)防治快捷指南[EB/OL].2012[2014—02-25].http://www.csao].cn/bencandy.php?aid=6246.
  • 8Apfel CC, Heidrich FM,Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting[J] . BrJ Anaesth, 2012, 109(5): 742-753.
  • 9Warr DG, Grunberg SM, Gralla RJ, et al. The oral NK 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting- Pooled data from 2 randomised, double-blind, placebo controlled trials[J]. EurJ Cancer, 2005, 41(9): 1278-1285.
  • 10Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron[J]. Ann Oncol, 2003, 14 ( 10) : 1570-1577.

共引文献580

同被引文献45

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部